bioAffinity Technologies launches $3.2M registered direct offering of common stock and warrants

bioAffinity Technologies entered into a placement agency agreement with WallachBeth Capital to sell up to $3.2 million in securities comprising common stock at $0.80 per share and pre-funded warrants at $0.793. The offering provides capital for the company through a registered direct offering under its Form S-1 registration statement.